Neuronetics: 4Q Earnings Snapshot

Associated Press
Updated ·1 min read

MALVERN, Pa. (AP) _ Neuronetics Inc. (STIM) on Tuesday reported a loss of $3.7 million in its fourth quarter.

On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 19 cents.

The medical device company focused on psychiatric disorders posted revenue of $15.6 million in the period.

For the year, the company reported that its loss narrowed to $27.5 million, or $1.46 per share. Revenue was reported as $49.2 million.

For the current quarter ending in April, Neuronetics said it expects revenue in the range of $11 million to $12 million.

The company expects full-year revenue in the range of $58 million to $62 million.

Neuronetics shares have increased 49% since the beginning of the year. The stock has climbed fivefold in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on STIM at https://www.zacks.com/ap/STIM